Phenomenome and BioServe Collaborate on Colorectal Cancer Dx, Plan Q4 US Launch | GenomeWeb
NEW YORK (GenomeWeb News) - BioServe and Phenomenome Discoveries have co-developed a serum-based colorectal cancer test that they hope to launch in the US in the fourth quarter of 2007, the companies said yesterday.
The companies said the test is currently available in Japan and in Canada and is available worldwide as a fee-for-service research-use-only tool.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.